Pharmascience Inc.

Canada


 
Quantité totale PI 48
Quantité totale incluant filiales 61 (+ 13 pour les filiales)
Rang # Quantité totale PI 29 215
Note d'activité PI 0,4/5.0    1
Rang # Activité PI 949 365
Parent Joddes Limited
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

0 0
0 14
34 0
0
 
Dernier brevet 2019 - Cholestyramine formulations and ...
Premier brevet 1997 - Modulation of iaps for the treat...
Dernière marque 2008 - Sélection du Pharmacien
Première marque 1937 - SECONAL

Filiales

2 subsidiaries with IP (13 patents, 0 trademarks)

1 subsidiaries without IP

 S'inscrire grtuitement pour accéder à la liste des filiales

Industrie (Classification de Nice)

Derniers inventions, produits et services

2019 Invention Cholestyramine formulations and methods of use. The present disclosure relates to cholestyramine ...
2018 Invention Pharmaceutical composition of entecavir and process of manufacturing. The present invention rela...
2017 Invention Abuse deterrent pharmaceutical composition. A modified release orally administrable abuse-deterr...
Invention Spirocyclic containing compounds and pharmaceutical uses thereof. The present invention rel...
Invention A smac mimetic compound for use in the treatment of proliferative diseases. The present invention...
2016 Invention Nystatin nanosuspension formulation using high pressure homogenisation. The present inventi...
Invention New benzimidazoles derivatives as tec kinases family inhibitors. The present invention relates to...
Invention Heterocyclic tec-family kinase inhibitors. Compounds having the Formula (I), and enantiomers, dia...
Invention Inhibitors of the tec kinase enzyme family. The present invention relates to a novel family of ki...
Invention A smac mimetic compound for use in the treatment of proliferative diseases. The present inv...
2015 Invention Orally disintegrating tablet of nabilone comprising mannitol-based granules. Orally disintegrati...
Invention Orally disintegrating tablet of nabilone comprising mannitol-based granules. Orally disintegratin...
2014 Invention Protein kinase inhibitors. The present invention relates to a novel family of protein kinase inh...
Invention Protein kinase inhibitors. The present invention relates to a novel family of protein kinase inhi...
Invention Abuse deterrent immediate release formulation. The present invention relates to an immediate rel...
Invention Abuse deterrent immediate release formulation. The present invention relates to an immediate rele...
Invention Iap bir domain binding compounds. A compound of Formula I or a salt thereof, methods for the pr...
Invention Orally disintegrating tablet of nabilone and method of manufacturing. The present invention...
2013 Invention Protein kinase inhibitors. The present invention relates to a novel family of protein kinas...
Invention Abuse deterrent pharmaceutical composition comprising konjac glucomannan. A modified release oral...
Invention Protein kinase inhibitors. The present invention relates to a novel family of inhibitors of prote...
Invention Abuse deterrent immediate release formulation. The present invention relates to an immediat...
Invention Pharmaceutical composition of entecavir and process of manufacturing. The present invention relat...
Invention Protein kinase inhibitors. The present invention relates to a novel family of inhibitors of...
2012 Invention Disintegrant-free delayed release doxylamine and pyridoxine formulation and process of manufactur...
Invention Pharmaceutical composition of amphetamine mixed salts. Orally administrable modified release phar...
Invention Abuse deterrent pharmaceutical formulation. A modified release orally administrable abuse-d...
Invention Pharmaceutical composition of entecavir and process of manufacturing. The present invention...
2011 Invention Disintegrant-free delayed release doxylamine and pyridoxine formulation and process of it manufac...
Invention Protein kinase inhibitors and uses thereof. The present invention relates to a new class of...
Invention Controlled release formulations of tolterodine and process of manufacturing. The present in...
2008 P/S Analgesics, cold treatment medication, cough treatment medication, acid reducer medication, aller...
2006 P/S Pharmaceutical preparations, namely Nasal decongestant.
1997 P/S Pharmaceutical preparations for the treatment of heartburn.
P/S Nutritional supplements, namely phenolic compounds, vitamins, or minerals.
1994 P/S Pharmaceutical packaging unit used to dispense unit-dose quantities of solutions for nebulization.
1993 P/S Pharmaceutical preparations, namely analgesics, antihistamines, anti-inflammatories, antibiotics,...
1983 P/S Sodium fluoride dental preparation.
1965 P/S Medicinal preparation for use as an analgesic.
1954 P/S Antiseptic preparation for surgical and hygienic use.
1953 P/S Pharmaceutical preparations consisting of combinations of analgesic and antipyretic.
1952 P/S Pharmaceutical preparations in the form of tablets consisting of a plurality of analgesic medicam...
1937 P/S Products of secondary amyl barbituric acid and the sodium salts thereof, useful as hypnotics.